Girard Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Girard Partners’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22	Closed	–	–	704
2018 Q3	$0	Buy	+22	New	+$498	﹤0.01%	955

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Girard Partners's SBRA Position: Q4 2018 in Review

Girard Partners sold out of Sabra Healthcare REIT (SBRA) in Q4 2018, closing a stake of 22 shares.

Girard Partners first reported a position in SBRA in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 362 funds tracked by Wall St. Rank hold SBRA as of Q4 2018.

Girard Partners reported no remaining Sabra Healthcare REIT position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 22 Sabra Healthcare REIT shares in Q4 2018.
Girard Partners first reported a position in Sabra Healthcare REIT in Q3 2018 and held it in 1 quarter.
Girard Partners's Sabra Healthcare REIT position peaked at $0 in Q3 2018.
362 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.